SNDX
Syndax Pharmaceuticals Inc

3,691
Mkt Cap
$1.45B
Volume
3.11M
52W High
$18.00
52W Low
$8.58
PE Ratio
-4.62
SNDX Fundamentals
Price
$17.05
Prev Close
$16.71
Open
$17.10
50D MA
$15.34
Beta
1.16
Avg. Volume
3.24M
EPS (Annual)
-$3.72
P/B
12.58
Rev/Employee
$87,703.70
Loading...
Loading...
News
all
press releases
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the twelve research firms that are presently covering the stock...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Syndax Pharmaceuticals, Inc. $SNDX Shares Purchased by Candriam S.C.A.
Candriam S.C.A. boosted its stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 49.9% in the 2nd quarter, according to the company in its most recent disclosure with the...
MarketBeat·5d ago
News Placeholder
Syndax Pharmaceuticals (NASDAQ:SNDX) Sets New 1-Year High - What's Next?
Syndax Pharmaceuticals (NASDAQ:SNDX) Reaches New 12-Month High - What's Next...
MarketBeat·6d ago
News Placeholder
Stock Traders Purchase High Volume of Syndax Pharmaceuticals Call Options (NASDAQ:SNDX)
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Get Free Report) was the target of some unusual options trading activity on Thursday. Investors purchased 6,219 call options on the company. This...
MarketBeat·6d ago
News Placeholder
JPMorgan Chase & Co. Issues Pessimistic Forecast for Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price
JPMorgan Chase & Co. lowered their price objective on shares of Syndax Pharmaceuticals from $40.00 to $33.00 and set an "overweight" rating on the stock in a research note on Wednesday...
MarketBeat·7d ago
News Placeholder
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 6.8% - Time to Buy?
Syndax Pharmaceuticals (NASDAQ:SNDX) Trading 6.8% Higher - What's Next...
MarketBeat·8d ago
News Placeholder
Simplify Asset Management Inc. Sells 122,736 Shares of Syndax Pharmaceuticals, Inc. $SNDX
Simplify Asset Management Inc. cut its holdings in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 83.1% in the 2nd quarter, according to its most recent disclosure with the...
MarketBeat·8d ago
News Placeholder
Syndax Pharmaceuticals (NASDAQ:SNDX) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Syndax Pharmaceuticals from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·13d ago
News Placeholder
PBYI's Q3 Earnings & Revenues Beat Estimates, 2025 Sales View Raised
Puma Biotechnology beats third-quarter estimates for earnings and revenues and lifts its 2025 outlook on stronger Nerlynx sales.
Zacks·13d ago
News Placeholder
ACAD Q3 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth
Acadia's third-quarter earnings and revenues top forecasts as Nuplazid and Daybue sales power double-digit annual growth.
Zacks·14d ago

Latest SNDX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.